AU2018904431A0 - Therapeutic Dendrimer - Google Patents

Therapeutic Dendrimer

Info

Publication number
AU2018904431A0
AU2018904431A0 AU2018904431A AU2018904431A AU2018904431A0 AU 2018904431 A0 AU2018904431 A0 AU 2018904431A0 AU 2018904431 A AU2018904431 A AU 2018904431A AU 2018904431 A AU2018904431 A AU 2018904431A AU 2018904431 A0 AU2018904431 A0 AU 2018904431A0
Authority
AU
Australia
Prior art keywords
dendrimer
therapeutic
therapeutic dendrimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018904431A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Starpharma Pty Ltd
Original Assignee
Starpharma Pty Ltd
Filing date
Publication date
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Publication of AU2018904431A0 publication Critical patent/AU2018904431A0/en
Priority to SG11202104239XA priority Critical patent/SG11202104239XA/en
Priority to PCT/AU2019/051274 priority patent/WO2020102852A1/en
Priority to KR1020217015503A priority patent/KR20210094541A/en
Priority to AU2019383466A priority patent/AU2019383466A1/en
Priority to US17/295,378 priority patent/US20220023290A1/en
Priority to EP19886880.4A priority patent/EP3883934A4/en
Priority to BR112021008318-9A priority patent/BR112021008318A2/en
Priority to CN201980075695.0A priority patent/CN113056469A/en
Priority to JP2021526735A priority patent/JP2022507615A/en
Priority to CA3119993A priority patent/CA3119993A1/en
Priority to MX2021005756A priority patent/MX2021005756A/en
Priority to CL2021001280A priority patent/CL2021001280A1/en
Priority to IL283327A priority patent/IL283327A/en
Abandoned legal-status Critical Current

Links

AU2018904431A 2018-11-20 2018-11-20 Therapeutic Dendrimer Abandoned AU2018904431A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MX2021005756A MX2021005756A (en) 2018-11-20 2019-11-20 Therapeutic dendrimer.
BR112021008318-9A BR112021008318A2 (en) 2018-11-20 2019-11-20 dendrimer, composition, cancer treatment method, use of a dendrimer, process for making a dendrimer and intermediates for making a dendrimer
CN201980075695.0A CN113056469A (en) 2018-11-20 2019-11-20 Therapeutic dendrimers
KR1020217015503A KR20210094541A (en) 2018-11-20 2019-11-20 therapeutic dendrimer
AU2019383466A AU2019383466A1 (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
US17/295,378 US20220023290A1 (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
EP19886880.4A EP3883934A4 (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
SG11202104239XA SG11202104239XA (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
PCT/AU2019/051274 WO2020102852A1 (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
JP2021526735A JP2022507615A (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
CA3119993A CA3119993A1 (en) 2018-11-20 2019-11-20 Therapeutic dendrimer
CL2021001280A CL2021001280A1 (en) 2018-11-20 2021-05-14 therapeutic dendrimer
IL283327A IL283327A (en) 2018-11-20 2021-05-20 Therapeutic dendrimer

Publications (1)

Publication Number Publication Date
AU2018904431A0 true AU2018904431A0 (en) 2018-12-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3463464A4 (en) Combination therapy
EP3768258A4 (en) Combination therapy
EP3873530A4 (en) Therapeutic methods
EP3651772A4 (en) Combination cancer therapy
EP3445750A4 (en) Therapeutic compounds
EP3796923A4 (en) Improved targeted t-cell therapy
EP3846678A4 (en) Therapeutic space assessment
EP3515414A4 (en) Combination therapy
EP3883934A4 (en) Therapeutic dendrimer
EP3668507A4 (en) Combination therapy
EP3860585A4 (en) Therapeutic compositions
EP3261678B8 (en) Antibody-urease conjugates for therapeutic purposes
EP3733175A4 (en) Cancer therapeutic
EP3630118A4 (en) Combination therapy
EP3609520A4 (en) Targeted combination therapy
EP3419959A4 (en) Combination therapy
EP3893874A4 (en) Crenolanib combination therapy
EP3684319A4 (en) Therapeutic device
EP4031143A4 (en) Therapeutic conjugates
EP3612522A4 (en) Therapeutic compounds
EP3576746A4 (en) Cancer therapeutic
EP3823961A4 (en) Therapeutic dendrimer
EP3976100A4 (en) Combination therapy
EP3717003A4 (en) Gp96-based cancer therapy
EP3675891A4 (en) Combination cancer therapy